Related Experiment Video
Updated: Oct 25, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
Su Gao1,2, Hailong Ruan3, Jingchong Liu3
1Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Ferroptosis is a novel form of cell death and plays a role in various diseases, especially tumors. It has been reported that ferroptosis is involved in the growth and progression of clear cell renal cell carcinoma (ccRCC); however, the specific molecular mechanisms are still unclear. In this study, we constructed a four-gene signature (FeSig) of ferroptosis-related genes via Cox regression analysis. ROC and survival analyses indicated that FeSig had good diagnostic and prognostic value. Further analysis revealed that ferroptosis was associated with tumor immunity in ccRCC. Next, weighted gene co-expression network analysis was performed to identify the potential regulatory mechanisms. Combined with correlation and survival analyses, the TAZ/WNT10B axis was identified as a tumor immune-related regulatory pathway. In conclusion, these findings suggest that ferroptosis is correlated with tumor immunity. The TAZ/WNT10B axis may be a novel biomarker and therapeutic target for immunotherapy in ccRCC.
Insights
Ferroptosis, a cell death form, impacts clear cell renal cell carcinoma (ccRCC). Researchers identified a ferroptosis gene signature (FeSig) for diagnosis and prognosis, revealing a link to tumor immunity and the TAZ/WNT10B pathway for potential ccRCC immunotherapy.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Ferroptosis is a distinct form of programmed cell death implicated in various diseases, particularly cancers.
- While ferroptosis is linked to clear cell renal cell carcinoma (ccRCC) progression, its precise molecular underpinnings remain largely unknown.
- Understanding ferroptosis's role in ccRCC is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To identify a ferroptosis-related gene signature for diagnosing and predicting outcomes in ccRCC.
- To investigate the association between ferroptosis and tumor immunity in ccRCC.
- To elucidate the molecular mechanisms, including potential regulatory pathways, underlying ferroptosis in ccRCC.
Main Methods:
- Cox regression analysis was used to construct a four-gene signature (FeSig) based on ferroptosis-related genes.
- Receiver Operating Characteristic (ROC) and survival analyses were performed to assess the diagnostic and prognostic capabilities of FeSig.
- Weighted gene co-expression network analysis (WGCNA) was employed to identify potential regulatory mechanisms, followed by correlation and survival analyses.
Main Results:
- The constructed four-gene signature (FeSig) demonstrated significant diagnostic and prognostic value in ccRCC.
- Ferroptosis was found to be significantly associated with tumor immunity in the context of ccRCC.
- The TAZ/WNT10B axis was identified as a key tumor immune-related regulatory pathway linked to ferroptosis in ccRCC.
Conclusions:
- Ferroptosis plays a significant role in ccRCC and is closely correlated with the tumor immune microenvironment.
- The TAZ/WNT10B signaling pathway emerges as a critical regulator in ferroptosis-associated immunity within ccRCC.
- The TAZ/WNT10B axis presents a promising novel biomarker and therapeutic target for advancing immunotherapy in ccRCC.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
The Extrinsic Apoptotic Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

